Daily Washington Insider
  • Business
  • World
  • Science
  • Investing

Daily Washington Insider

  • Business
  • World
  • Science
  • Investing
Investing

Anglo Takes Third De Beers Writedown in Three Years

by admin February 21, 2026
February 21, 2026
Anglo Takes Third De Beers Writedown in Three Years

Anglo American (LSE:AAL,OTCQX:NGLOY) has slashed the value of its De Beers diamond business by US$2.3 billion, cutting the unit’s carrying value in half and pushing the FTSE 100 miner to a US$3.7 billion annual loss as a prolonged slump in the global diamond market deepens.

After previous charges of US$2.6 billion in 2023 and US$2.9 billion in 2024, De Beers is now valued at US$2.3 billion—a fraction of what it was worth just a few years ago.

The impairment drove Anglo to a net loss of US$3.7 billion for the year, compared with a US$3 billion loss previously. Losses at De Beers also widened sharply to US$511 million from just $25 million the year before, as the business recorded a third straight annual drop in production and trimmed its 2026 output forecast.

“There is at the moment a plentiful supply of rough diamonds in the market,” CEO Duncan Wanblad told reporters.

The diamond sector has been squeezed by several forces at once. US tariffs on India, where most rough diamonds are polished, have disrupted trade flows. Competition from lab-grown stones has also intensified, leading to the erosion of pricing power held by market players.

Anglo has been trying to exit diamonds as part of a sweeping restructuring announced after it fended off a £39 billion takeover approach from BHP (ASX:BHP,NYSE:BHP,LSE:BHP) in 2024. The plan includes divesting its diamond, coal, and platinum units and refocusing on copper and iron ore.

Wanblad said the sale of Anglo’s 85 percent stake in De Beers is at an advanced stage, with several credible bidders in the process alongside discussions with Botswana. The country currently owns 15 percent of the business and supplies about 70 percent of its annual rough diamond output.

Wanblad said he is “optimistic” that the company would “see a deal signed” this year.

Despite the hit from De Beers, Anglo’s underlying earnings before interest, tax, depreciation and amortisation rose 2 percent to US$6.4 billion, buoyed by strong copper prices. The company declared a dividend of US$0.23 per share, down from US$0.64 a year earlier, while net debt fell to US$8.6 billion.

Copper and iron ore remain the miner’s core profit drivers and are expected to anchor earnings once the restructuring is complete.

Anglo’s proposed combination with Canada’s Teck Resources (TSX:TECK.A,TECK.B,NYSE:TECK,OTCPL:TCKRF), which would expand its copper portfolio with assets including the Quebrada Blanca mine in Chile, has been approved by shareholders and is awaiting regulatory clearance.

Still, diamonds remain a drag at a time when the broader industry is facing structural change. Producers are currently grappling with falling prices, lab-grown competition, and shifting consumer trends.

Securities Disclosure: I, Giann Liguid, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

0
FacebookTwitterGoogle +Pinterest
previous post
Cellulose Breakthrough Could Simplify Rare Earths Separation
next post
Crypto Market Update: White House Pushes for Compromise in Stablecoin Negotiations

You may also like

Cardiol Therapeutics Completes US$11.4 Million Financing and Extends...

October 21, 2025

Next Generation DLE Provider Electralith Produces 99.9% Pure...

May 7, 2024

Brien Lundin: Gold, Silver Waiting for Next Leg,...

November 6, 2025

400% Increase in Antimony Target Strike Length

October 10, 2025

Tech Weekly: Semiconductor Stocks Rally on Fed Rate...

September 22, 2025

Tech 5: TSMC Gets US$6.6 Billion Biden Admin...

November 16, 2024

Brunswick Exploration Announces AGM Results

June 14, 2025

Nuclear Fuels Acquires TenSleep Uranium Project with Athabasca...

March 3, 2025

9 Experts Share Highest-Conviction Sectors for 2026

January 4, 2026

5 Best-performing Canadian Pharma Stocks (Updated January 2025)

January 12, 2025

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Popular

    • 1

      Hong Kong plans to install thousands of surveillance cameras. Critics say it’s...

    • 2

      UN experts urge Thailand not to deport dozens of Uyghurs to China where they face ‘real risk of torture’

    • 3

      Trump has assembled a team of China hawks. How will Beijing respond?

    • 4

      China executes man who plowed car into crowds in deadliest attack in a decade

    • 5

      How Calvin Klein and Tommy Hilfiger got caught in Trump’s trade war with China

    Categories

    • Business (1,388)
    • Investing (4,679)
    • Science (605)
    • World (3,677)
    Footer Logo

    Disclaimer: dailywashingtoninsider.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 dailywashingtoninsider.com | All Rights Reserved